In GBM constitutive EGFR activation due to mutations or gene amplification causes deregulated proliferation, angiogenesis, and inhibition of apoptosis; for this reason, bypassing the apoptotic pathway to induce cancer cell death can be considered a promising approach to overcoming this problem [18–20]. The gene discussed is EGFR; the disease is glioblastoma.